Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending September 18, 2021 (Week 37)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †Current weekPrevious 52 weeks Max †Cum YTD 2021 †Cum YTD 2020 †
U.S. Residents, excluding U.S. Territories 115 197 5,174 8,796 6 9 117 151
New England 1 19 215 510 - 1 1 4
Connecticut - 5 47 129 - 0 - 1
Maine - 10 51 64 - 0 - -
Massachusetts 1 6 78 197 - 1 - -
New Hampshire - 3 22 60 - 1 1 2
Rhode Island - 3 14 37 - 0 - -
Vermont - 1 3 23 - 1 - 1
Middle Atlantic 9 44 706 1,384 3 6 40 53
New Jersey 1 11 88 320 3 3 22 28
New York (excluding New York City) 3 26 222 362 - 2 6 8
New York City 4 14 196 366 - 6 8 6
Pennsylvania 1 14 200 336 - 1 4 11
East North Central 3 38 914 1,617 - 2 18 35
Illinois N NC N N N NC N N
Indiana - 14 220 326 - 1 - 2
Michigan - 12 169 414 - 2 4 1
Ohio - 19 384 652 - 2 14 32
Wisconsin 3 7 141 225 - 0 - -
West North Central 2 14 221 438 - 2 15 11
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - 2 - 0 - -
Missouri - 10 125 287 - 2 7 5
Nebraska 2 4 51 81 - 0 - 2
North Dakota - 3 15 34 - 0 - -
South Dakota - 3 30 34 - 2 8 4
South Atlantic 27 40 1,059 1,410 1 2 13 14
Delaware 3 4 40 49 - 0 - -
District of Columbia - 2 12 44 - 0 - -
Florida 18 24 444 462 1 2 8 8
Georgia 3 18 276 370 - 0 - -
Maryland 3 8 126 255 - 1 2 -
North Carolina N NC N N N NC N N
South Carolina - 8 60 80 - 2 3 3
Virginia - 2 8 9 - 0 - -
West Virginia - 13 93 141 - 0 - 3
East South Central 32 28 602 962 - 2 5 4
Alabama 5 13 175 209 - 1 1 -
Kentucky 2 5 72 183 - 1 4 2
Mississippi 4 7 100 142 - 0 - -
Tennessee 21 15 255 428 - 0 - 2
West South Central 15 55 558 963 1 3 15 17
Arkansas 4 10 88 157 - 1 - 1
Louisiana 4 13 140 206 - 1 1 3
Oklahoma N NC N N N NC N N
Texas 7 46 330 600 1 3 14 13
Mountain 15 46 768 1,368 - 2 9 6
Arizona 9 38 419 500 - 1 3 2
Colorado - 13 - 288 - 0 - 1
Idaho N NC N N N NC N N
Montana - 4 52 63 - 0 - 2
Nevada 1 8 75 208 - 1 2 -
New Mexico 3 7 119 163 - 0 - -
Utah 2 9 85 124 - 1 4 1
Wyoming - 2 18 22 - 0 - -
Pacific 11 12 131 144 1 1 1 7
Alaska 10 10 110 114 1 1 1 7
California N NC N N N NC N N
Hawaii 1 3 21 30 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 1 1 - - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 1 1 - - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 115 197 5,175 8,796 6 9 117 151
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2020 and 2021 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.